{{Rsnum
|rsid=1044129
|Gene=RYR3
|Chromosome=15
|position=33866065
|Orientation=plus
|GMAF=0.4275
|Gene_s=AVEN,RYR3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 5.3 | 39.8 | 54.9
| HCB | 23.7 | 58.5 | 17.8
| JPT | 39.6 | 38.7 | 21.6
| YRI | 51.0 | 42.1 | 6.9
| ASW | 45.6 | 40.4 | 14.0
| CHB | 23.7 | 58.5 | 17.8
| CHD | 35.8 | 48.6 | 15.6
| GIH | 26.7 | 54.5 | 18.8
| LWK | 42.7 | 45.5 | 11.8
| MEX | 6.9 | 37.9 | 55.2
| MKK | 61.5 | 33.3 | 5.1
| TSI | 6.9 | 44.6 | 48.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=21810988
|Title=Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification
|OA=1
}}

{{PMID Auto
|PMID=17584784
|Title=Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers.
|OA=1
}}

{{PMID Auto
|PMID=23393343
|Title=Functional Polymorphism in the MicroRNA-367 Binding Site as a Prognostic Factor for Colonic Cancer
}}

{{PMID Auto
|PMID=24530479
|Title=A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma
}}

{{PMID Auto
|PMID=24831772
|Title=A polymorphism at the microRNA binding site in the 3' untranslated region of C14orf101 is associated with non-Hodgkin lymphoma overall survival
}}

{{PMID Auto
|PMID=24922658
|Title=Genetic Polymorphism of miR-196a as a Prognostic Biomarker for Early Breast Cancer
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}